USP11 augments TGFβ signaling by deubiquitylating ALK5

Open Biology

Volumn 2, Issue JUNE, 2012, Pages

  Al Salihi, Mazin A ^a   Herhaus, Lina ^a   MacArtney, Thomas ^a   Sapkota, Gopal P ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

ALK5; Cancer; TGF ; Ubiquitin; USP11; USP15

Indexed keywords

PROTEIN SERINE THREONINE KINASE; SMAD PROTEIN; TGF BETA TYPE I RECEPTOR; TGF-BETA TYPE I RECEPTOR; THIOL ESTER HYDROLASE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; UBIQUITIN; UBIQUITIN PROTEIN LIGASE; USP11 PROTEIN, HUMAN;

ALK5; ANIMAL; ARTICLE; CELL STRAIN HEK293; EPITHELIAL MESENCHYMAL TRANSITION; GENETIC TRANSCRIPTION; GENETICS; HUMAN; METABOLISM; MOUSE; NEOPLASM; PHOSPHORYLATION; PHYSIOLOGY; RNA INTERFERENCE; SIGNAL TRANSDUCTION; TGFΒ; UBIQUITINATION; USP11; USP15;

ALK5; CANCER; TGFΒ; UBIQUITIN; USP11; USP15;

ANIMALS; EPITHELIAL-MESENCHYMAL TRANSITION; HEK293 CELLS; HUMANS; MICE; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA INTERFERENCE; SIGNAL TRANSDUCTION; SMAD PROTEINS; THIOLESTER HYDROLASES; TRANSCRIPTION, GENETIC; TRANSFORMING GROWTH FACTOR BETA; UBIQUITIN-PROTEIN LIGASES; UBIQUITINATION;

EID: 84864240454     PISSN: None     EISSN: 20462441     Source Type: Journal    
DOI: 10.1098/rsob.120063     Document Type: Article

References (48)

1. Massagué J. 1998 TGF-beta signal transduction. Annu. Rev. Biochem. 67, 753-791. (doi:10.1146/ annurev.biochem.67.1.753)
2. Shi Y, Massagué J. 2003 Mechanisms of TGF-beta signaling from cell membrane to the nucleus. Cell 113, 685-700. (doi:10.1016/S0092-8674(03) 00432-X) (Pubitemid 36724933)
3. Ikushima H, Miyazono K. 2011 TGF-b signal transduction spreading to a wider field: a broad variety of mechanisms for context-dependent effects of TGF-b. Cell Tissue Res. 347, 37-49. (doi:10.1007/s00441-011-1179-5)
4. Santibañez JF, Quintanilla M, Bernabeu C. 2011 TGFb/ TGF-b receptor system and its role in physiological and pathological conditions. Clin. Sci. (Lond.) 121, 233-251. (doi:10.1042/CS20110086)
5. Massagué J. 2008 TGFbeta in cancer. Cell 134, 215-230. (doi:10.1016/j.cell.2008.07.001) (Pubitemid 352010335)
6. Massagué J, Gomis RR. 2006 The logic of TGFbeta signaling. FEBS. Lett. 580, 2811-2820. (doi:10. 1016/j.febslet.2006.04.033)
7. Yan X, Liu Z, Chen Y. 2009 Regulation of TGF-beta signaling by Smad7. Acta Biochim. Biophys. Sin. (Shanghai) 41, 263-272. (doi:10.1093/abbs/gmp018)
8. Liu IM, Schilling SH, Knouse KA, Choy L, Derynck R, Wang XF. 2009 TGFbeta-stimulated Smad1/5 phosphorylation requires the ALK5 L45 loop and mediates the pro-migratory TGFbeta switch. EMBO J. 28, 88-98. (doi:10.1038/emboj.2008.266)
9. Pickart CM, Eddins MJ. 2004 Ubiquitin: structures, functions, mechanisms. Biochim. Biophys. Acta 1695, 55-72. (doi:10.1016/j.bbamcr.2004.09.019) (Pubitemid 39585154)
10. Soond SM, Chantry A. 2011 How ubiquitination regulates the TGF-b signalling pathway: new insights and new players: new isoforms of ubiquitin-activating enzymes in the E1-E3 families join the game. Bioessays 33, 749-758. (doi:10. 1002/bies.201100057)
11. Al-Salihi MA, Herhaus L, Sapkota G. 2012 Regulation of the transforming growth factor b pathway by reversible ubiquitylation. Open Biol. 2, 120082. (doi:10.1098/rsob.120082)
12. Lin X, Liang M, Feng XH. 2000 Smurf2 is a ubiquitin E3 ligase mediating proteasome-dependent degradation of Smad2 in transforming growth factor-beta signaling. J. Biol. Chem. 275, 36 818-36 822. (doi:10.1074/jbc.C000580200) (Pubitemid 32002092)
13. Izzi L, Attisano L. 2004 Regulation of the TGFbeta signalling pathway by ubiquitin-mediated degradation. Oncogene 23, 2071-2078. (doi:10. 1038/sj.onc.1207412) (Pubitemid 38496736)
14. Sapkota G, Alarcón C, Spagnoli FM, Brivanlou AH, Massagué J. 2007 Balancing BMP signaling through integrated inputs into the Smad1 linker. Mol. Cell 25, 441-454. (doi:10.1016/j.molcel.2007.01.006) (Pubitemid 46199289)
15. Gao S et al. 2009 Ubiquitin ligase Nedd4L targets activated Smad2/3 to limit TGF-beta signaling. Mol. Cell 36, 457-468. (doi:10.1016/j.molcel. 2009.09.043)
16. Dupont S et al. 2009 FAM/USP9x, a deubiquitinating enzyme essential for TGFbeta signaling, controls Smad4 monoubiquitination. Cell 136, 123-135. (doi:10.1016/j.cell.2008.10.051)
17. Kavsak P, Rasmussen RK, Causing CG, Bonni S, Zhu H, Thomsen GH, Wrana JL. 2000 Smad7 binds to Smurf2 to form an E3 ubiquitin ligase that targets the TGF beta receptor for degradation. Mol. Cell 6, 1365-1375. (doi:10.1016/S1097- 2765(00)00134-9) (Pubitemid 32045929)
18. Itoh S, ten Dijke P. 2007 Negative regulation of TGF-beta receptor/Smad signal transduction. Curr. Opin. Cell Biol. 19, 176-184. (doi:10.1016/j.ceb. 2007.02.015) (Pubitemid 46386411)
19. Koinuma D et al. 2003 Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7. EMBO J. 22, 6458-6470. (doi:10.1093/ emboj/cdg632) (Pubitemid 38009594)
20. Wicks SJ, Haros K, Maillard M, Song L, Cohen RE, Dijke PT, Chantry A. 2005 The deubiquitinating enzyme UCH37 interacts with Smads and regulates TGF-beta signalling. Oncogene 24, 8080-8084. (doi:10.1038/sj.onc.1208944) (Pubitemid 41746751)
21. Inui M et al. 2011 USP15 is a deubiquitylating enzyme for receptor-activated SMADs. Nat. Cell Biol. 13, 1368-1375. (doi:10.1038/ncb2346)
22. Zhao Y, Thornton AM, Kinney MC, Ma CA, Spinner JJ, Fuss IJ, Shevach EM, Jain A. 2011 The deubiquitinase CYLD targets Smad7 protein to regulate transforming growth factor b (TGF-b) signaling and the development of regulatory T cells. J. Biol. Chem. 286, 40 520-40 530. (doi:10. 1074/jbc.M111.292961)
23. Komander D, Clague MJ, Urbé S. 2009 Breaking the chains: structure and function of the deubiquitinases. Nat. Rev. Mol. Cell Biol. 10, 550-563. (doi:10.1038/nrm2731)
24. Ideguchi H, Ueda A, Tanaka M, Yang J, Tsuji T, Ohno S, Hagiwara E, Aoki A, Ishigatsubo Y. 2002 Structural and functional characterization of the USP11 deubiquitinating enzyme, which interacts with the RanGTP-associated protein RanBPM. Biochem. J. 367, 87-95. (doi:10.1042/BJ20011851) (Pubitemid 35176894)
25. Schoenfeld AR, Apgar S, Dolios G, Wang R, Aaronson SA. 2004 BRCA2 is ubiquitinated in vivo and interacts with USP11, a deubiquitinating enzyme that exhibits prosurvival function in the cellular response to DNA damage. Mol. Cell Biol. 24, 7444-7455. (doi:10.1128/MCB.24.17.7444-7455.2004) (Pubitemid 39121473)
26. Lin CH, Chang HS, Yu WCY. 2008 USP11 stabilizes HPV-16E7 and further modulates the E7 biological activity. J. Biol. Chem. 283, 15 681-15 688. (doi:10.1074/jbc.M708278200)
27. Yamaguchi T, Kimura J, Miki Y, Yoshida K. 2007 The deubiquitinating enzyme USP11 controls an IkappaB kinase alpha (IKKalpha)-p53 signaling pathway in response to tumor necrosis factor alpha (TNFalpha). J. Biol. Chem. 282, 33 943-33 948. (Pubitemid 350159476)
28. Liao TL, Wu CY, Su WC, Jeng KS, Lai MMC. 2010 Ubiquitination and deubiquitination of NP protein regulates influenza A virus RNA replication. EMBO J. 29, 3879-3890. (doi:10.1038/emboj.2010.250)
29. Wiltshire TD, Lovejoy CA, Wang T, Xia F, OConnor MJ, Cortez D. 2010 Sensitivity to poly(ADP-ribose) polymerase (PARP) inhibition identifies ubiquitinspecific peptidase 11 (USP11) as a regulator of DNA double-strand break repair. J. Biol. Chem. 285, 14 565-14 571. (doi:10.1074/jbc.M110. 104745)
30. Sun W et al. 2010 USP11 negatively regulates TNFalpha-induced NF-kappaB activation by targeting on IkappaBalpha. Cell. Signal. 22, 386-394. (doi:10.1016/j.cellsig.2009.10.008)
31. Bernassola F, Karin M, Ciechanover A, Melino G. 2008 The HECT family of E3 ubiquitin ligases: multiple players in cancer development. Cancer Cell 14, 10-21. (doi:10.1016/j.ccr.2008.06.001) (Pubitemid 351885498)
32. Eichhorn PJA et al. 2012 USP15 stabilizes TGF-b receptor I and promotes oncogenesis through the activation of TGF-b signaling in glioblastoma. Nat. Med. 18, 429-435. (doi:10.1038/nm.2619)
33. Lu Z, Murray JT, Luo W, Li H, Wu X, Xu H, Backer JM, Chen YG. 2002 Transforming growth factor beta activates Smad2 in the absence of receptor endocytosis. J. Biol. Chem. 277, 29 363-29 368. (doi:10.1074/jbc.M203495200) (Pubitemid 41079219)
34. Runyan CE, Schnaper HW, Poncelet AC. 2005 The role of internalization in transforming growth factor beta1-induced Smad2 association with Smad anchor for receptor activation (SARA) and Smad2-dependent signaling in human mesangial cells. J. Biol. Chem. 280, 8300-8308. (doi:10.1074/jbc. M407939200) (Pubitemid 40349732)
35. Song CZ, Siok TE, Gelehrter TD. 1998 Smad4/DPC4 and Smad3 mediate transforming growth factorbeta (TGF-beta) signaling through direct binding to a novel TGF-beta-responsive element in the human plasminogen activator inhibitor-1 promoter. J. Biol. Chem. 273, 29 287-29 290. (doi:10.1074/jbc.273.45.29287) (Pubitemid 28509925)
36. Norwitz ER, Xu S, Xu J, Spiryda LB, Park JS, Jeong KH, McGee EA, Kaiser UB. 2002 Direct binding of AP-1 (Fos/Jun) proteins to a SMAD binding element facilitates both gonadotropin-releasing hormone (GnRH)-and activin-mediated transcriptional activation of the mouse GnRH receptor gene. J. Biol. Chem. 277, 37 469-37 478. (doi:10.1074/jbc.M206571200)
37. Knockaert M, Sapkota G, Alarcón C, Massagué J, Brivanlou AH. 2006 Unique players in the BMP pathway: small C-terminal domain phosphatases dephosphorylate Smad1 to attenuate BMP signaling. Proc. Natl Acad. Sci. USA 103, 11 940-11 945. (doi:10.1073/pnas.0605133103) (Pubitemid 44215790)
38. Tang Y, Liu Z, Zhao L, Clemens TL, Cao X. 2008 Smad7 stabilizes beta-catenin binding to E-cadherin complex and promotes cell-cell adhesion. J. Biol. Chem. 283, 23 956-23 963. (doi:10.1074/jbc. M800351200)
39. Lee YS, Kim JH, Kim ST, Kwon JY, Hong S, Kim SJ, Park SH. 2010 Smad7 and Smad6 bind to discrete regions of Pellino-1 via their MH2 domains to mediate TGF-beta1-induced negative regulation of IL-1R/TLR signaling. Biochem. Biophys. Res. Commun. 393, 836-843. (doi:10.1016/j.bbrc. 2010.02.094)
40. Hao X, Wang Y, Ren F, Zhu S, Ren Y, Jia B, Li YP, Shi Y, Chang Z. 2011 SNX25 regulates TGF-b signaling by enhancing the receptor degradation. Cell. Signal. 23, 935-946. (doi:10.1016/j.cellsig.2011.01.022)
41. Upadhyay G, Yin Y, Yuan H, Li X, Derynck R, Glazer RI. 2011 Stem cell antigen-1 enhances tumorigenicity by disruption of growth differentiation factor-10 (GDF10)-dependent TGFbeta signaling. Proc. Natl Acad. Sci. USA 108, 7820-7825. (doi:10.1073/pnas.1103441108)
42. Guglielmo GMD, Roy CL, Goodfellow AF, Wrana JL. 2003 Distinct endocytic pathways regulate TGF-beta receptor signalling and turnover. Nat. Cell Biol. 5, 410-421. (doi:10.1038/ncb975) (Pubitemid 36592263)
43. Gal A, Sjöblom T, Fedorova L, Imreh S, Beug H, Moustakas A. 2008 Sustained TGF beta exposure suppresses Smad and non-Smad signalling in mammary epithelial cells, leading to EMT and inhibition of growth arrest and apoptosis. Oncogene 27, 1218-1230. (doi:10.1038/sj.onc.1210741) (Pubitemid 351294691)
44. Moreno-Bueno G, Peinado H, Molina P, Olmeda D, Cubillo E, Santos V, Palacios J, Portillo F, Cano A. 2009 The morphological and molecular features of the epithelial-to-mesenchymal transition. Nat. Protoc. 4, 1591-1613. (doi:10.1038/nprot. 2009.152)
45. Roussos ET, Keckesova Z, Haley JD, Epstein DM, Weinberg RA, Condeelis JS. 2010 AACR special conference on epithelial-mesenchymal transition and cancer progression and treatment. Cancer Res. 70, 7360-7364. (doi:10.1158/0008-5472. CAN-10-1208)
46. Vogt J, Traynor R, Sapkota GP. 2011 The specificities of small molecule inhibitors of the TGFβ and BMP pathways. Cell. Signal. 23, 1831-1842. (doi:10. 1016/j.cellsig.2011.06.019)
47. Durocher Y, Perret S, Kamen A. 2002 High-level and high-throughput recombinant protein production by transient transfection of suspension-growing human 293-EBNA1 cells. Nucleic Acids Res. 30, E9. (doi:10. 1093/nar/30.2.e9)
48. Peng C, Knebel A, Morrice NA, Li X, Barringer K, Li J, Jakes S, Werneburg B, Wang L. 2007 Pim kinase substrate identification and specificity. J. Biochem. 141, 353-362. (doi:10.1093/jb/mvm040) (Pubitemid 46770388)